Forbes -
11 Feb 2015 18:44
In trading on Wednesday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 1.3% on the day. Components of that ETF showing particular strength include shares of Sangamo Biosciences (SGMO), up about 16.2% and shares of Exelixis (EXEL), up about 10.1% on the day.
Share this Article
Comment on this Article
Please to comment